Understanding biomarkers for Alzheimer's disease and related disorders
South Texas Alzheimer’s Disease Center Biomarker Core
This study is looking for people with Alzheimer's, their caregivers, and healthy individuals to help collect samples that could lead to better ways to diagnose the disease and understand how it progresses, so we can improve care for everyone affected by Alzheimer's.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Science Center NIH-funded |
| Lab location | 1 site (San Antonio, United States) |
| Project ID | NIH-10880638 on NIH RePORTER |
What this research studies
This research focuses on collecting and analyzing biological samples from individuals with Alzheimer's disease and related disorders to improve diagnosis and risk prediction. The study aims to gather biospecimens from patients, their caregivers, and healthy controls to identify biomarkers that can detect early signs of the disease and predict its progression. By tracking these samples over time, researchers hope to enhance our understanding of Alzheimer's and develop better diagnostic tools. Patients enrolled will have their samples processed and stored for future analysis, contributing to a larger effort to combat Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates include individuals diagnosed with Alzheimer's disease or related dementias, as well as their caregivers and healthy controls.
Not a fit: Patients with other unrelated neurological conditions or those not diagnosed with Alzheimer's disease or related dementias may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier diagnosis and better management of Alzheimer's disease, ultimately improving patient outcomes.
How similar studies have performed: Previous research has shown promise in using biomarkers for Alzheimer's diagnosis, indicating that this approach has potential for significant advancements in the field.
Where this research is happening
San Antonio, United States
- University of Texas Hlth Science Center — San Antonio, United States (Active)
Researchers
- Principal investigator: Han, Xianlin — University of Texas Hlth Science Center
- Study coordinator: Han, Xianlin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.